Selective intestinal decontamination with norfloxacin enhances a regulatory T cell‐mediated inflammatory control mechanism in cirrhosis
- 21 June 2016
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 36 (12) , 1811-1820
Abstract
Background & Aims: Norfloxacin exerts immunomodulatory effects in cirrhosis beyond its bactericidal activity. We aimed at identifying the role of regulatory T (Treg) cells in the norfloxacin mechanism that compensates the inflammatory environment in cirrhosis.Patients & Methods: Consecutively admitted patients with cirrhosis and ascitic fluid (AF) with: spontaneous bacterial peritonitis (SBP), non‐infected AF, and norfloxacin as secondary SBP prophylaxis (SID group). Tregs were defined by flow‐cytometry as CD4+CD25+FoxP3+ cells. Dendritic cells (DCs) were purified for co‐stimulatory signalling evaluation and norfloxacin and IL‐10 levels were measured in serum. Wildtype and recombination activating gene 1 (Rag1)‐deficient mice with CCl4‐induced cirrhosis were used for adoptive‐transfer experiments using naïve CD4+ T cells and Tregs.Results: Eighty‐four patients were included. Treg percentage was significantly increased in SID patients compared with SBP or non‐infected AF patients. A positive correlation was observed between Tregs and serum norfloxacin and IL‐10 levels. DCs from SID patients showed a significantly decreased expression of CD80 and CD86 compared with SBP and non‐infected AF patients and correlated with norfloxacin levels. Modulation of co‐stimulatory signalling by norfloxacin was not detected in Rag1‐deficient mice and Rag1‐deficient mice reconstituted with naïve T‐cells. However, reconstitution with naïve T‐cells and Tregs was associated with significantly downregulated CD80 and CD86 expression in the presence of norfloxacin. Norfloxacin immunomodulatory effect on IL‐2 and IFN‐gamma reduction and on the increase of IL‐10 was significantly achieved only when the Tregs were restored in Rag1‐deficient mice.Conclusions: These results provide a plausible mechanism for the immunomodulatory effects of norfloxacin in cirrhosis beyond its bactericidal effect.Keywords
Funding Information
- Instituto de Salud Carlos III (PI13/1443)
- Federación Española de Enfermedades Raras
This publication has 35 references indexed in Scilit:
- Interaction between intestinal dendritic cells and bacteria translocated from the gut in rats with cirrhosisHepatology, 2012
- Competition for IL-2 between Regulatory and Effector T Cells to Chisel Immune ResponsesFrontiers in Immunology, 2012
- Gut Microbiota Dysbiosis Is Associated with Inflammation and Bacterial Translocation in Mice with CCl4-Induced FibrosisPLOS ONE, 2011
- Bacterial strain‐specific induction of Foxp3+ T regulatory cells is protective in murine allergy modelsClinical & Experimental Allergy, 2010
- Norfloxacin Modulates the Inflammatory Response and Directly Affects Neutrophils in Patients With Decompensated CirrhosisGastroenterology, 2009
- Commensal-Induced Regulatory T Cells Mediate Protection against Pathogen-Stimulated NF-κB ActivationPLOS Pathogens, 2008
- Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitisHepatology, 2008
- Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangementHepatology, 2003
- Introduction1997
- Effects of quinolones on tumor necrosis factor production by human monocytesInternational Journal of Immunopharmacology, 1990